Aquestive Therapeutics Inc (AQST) — Strategic Asset Allocation Index
Aquestive Therapeutics Inc (AQST) has a Strategic Asset Allocation Index of 121.1% as of December 2018. Strategic assets (PP&E of $12.21 Million plus long-term investments of $-) total $12.21 Million, measured against net assets of $10.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check AQST asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Aquestive Therapeutics Inc Strategic Asset Allocation Index (2005–2018)
This chart shows how Aquestive Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2005 to 2018. As of December 2018, the index stands at 121.1%, representing strategic assets of $12.21 Million against net assets of $10.08 Million USD. See Aquestive Therapeutics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Aquestive Therapeutics Inc (2005–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for Aquestive Therapeutics Inc from 2005 to 2018, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see AQST stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 121.1% | $12.21 Million | $12.21 Million | $- | $10.08 Million | ▲ +87.2 pp |
| 2006 | 33.9% | $8.56 Million | $8.56 Million | $- | $25.26 Million | ▼ -129.3 pp |
| 2005 | 163.2% | $7.61 Million | $7.61 Million | $- | $4.67 Million | — |